Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  danazol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase II/III Randomized Study of TMX/FXM vs TMX/Danazol for Metastatic Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-81-C-72, NCI-MB-153, NCI-T83-1460N, T83-1460
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000067139, GOG-0180, NCT00003946
Phase II Endocrine Treatment with TMX vs Danazol or a Progestational Agent for Advanced Nonresectable Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCSF-250802-01, NCI-V85-0030
Phase II Randomized Study of Chemotherapy with Isotretinoin vs Danazol in Patients with Favorable Myelodysplastic Syndromes (Summary Last Modified 03/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-878152, MAYO-878152, NCCTG-87-81-52
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PNH-2012, NCT01642979
Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC1283, NCI-2012-02201, P30CA015083, NCT01732445
Start Over